Vortioxetine‐induced syndrome of inappropriate secretion of antidiuretic hormone: A case report
Sign Up to like & getrecommendations! Published in 2024 at "Neuropsychopharmacology Reports"
DOI: 10.1002/npr2.12438
Abstract: Vortioxetine, known for its efficacy in treating depression through its effects on various neurotransmitters, has not been previously reported to induce syndrome of inappropriate secretion of antidiuretic hormone (SIADH). read more here.
Keywords: secretion antidiuretic; syndrome inappropriate; vortioxetine; inappropriate secretion ... See more keywords
Nedaplatin-induced syndrome of inappropriate secretion of antidiuretic hormone: A case report and review of the literature
Sign Up to like & getrecommendations! Published in 2021 at "World Journal of Clinical Cases"
DOI: 10.12998/wjcc.v9.i23.6810
Abstract: BACKGROUND Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is relatively common in several cancers, such as small cell lung cancer. However, nedaplatin-induced SIADH is rare. We describe a case of SIADH mediated by nedaplatin.… read more here.
Keywords: secretion antidiuretic; inappropriate secretion; antidiuretic hormone; case ... See more keywords
Pazopanib-induced posterior reversible encephalopathy syndrome with possible syndrome of inappropriate secretion of antidiuretic hormone: an incidental or pathophysiological association?
Sign Up to like & getrecommendations! Published in 2020 at "Neural Regeneration Research"
DOI: 10.4103/1673-5374.270420
Abstract: Introduction: Pazopanib is an oral protein kinase inhibitor (PKI) that targets vascular endothelial growth factor (VEGF) receptors, fibroblastic growth factor receptors, platelet-derived growth factor receptors, and stem cell factor that inhibits VEGF-induced cellular proliferation. Pazopanib… read more here.
Keywords: pazopanib; encephalopathy syndrome; inappropriate secretion; posterior reversible ... See more keywords